Laurens A van Meeteren
Laurens A van Meeteren
Verified email at
Cited by
Cited by
The ins and outs of lysophosphatidic acid signaling
WH Moolenaar, LA van Meeteren, BNG Giepmans
Bioessays 26 (8), 870-881, 2004
Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development
LA Van Meeteren, P Ruurs, C Stortelers, P Bouwman, MA van Rooijen, ...
Molecular and cellular biology, 2006
Vascular endothelial growth factor B controls endothelial fatty acid uptake
CE Hagberg, A Falkevall, X Wang, E Larsson, J Huusko, I Nilsson, ...
Nature 464 (7290), 917-921, 2010
Regulation and biological activities of the autotaxin–LPA axis
LA Van Meeteren, WH Moolenaar
Progress in lipid research 46 (2), 145-160, 2007
Regulation of endothelial cell plasticity by TGF-β
LA van Meeteren, P Ten Dijke
Cell and tissue research 347 (1), 177-186, 2012
Structural basis of substrate discrimination and integrin binding by autotaxin
J Hausmann, S Kamtekar, E Christodoulou, JE Day, T Wu, Z Fulkerson, ...
Nature structural & molecular biology 18 (2), 198-204, 2011
Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate
LA Van Meeteren, P Ruurs, E Christodoulou, JW Goding, H Takakusa, ...
Journal of Biological Chemistry 280 (22), 21155-21161, 2005
Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation
HMHG Albers, A Dong, LA van Meeteren, DA Egan, M Sunkara, ...
Proceedings of the National Academy of Sciences 107 (16), 7257-7262, 2010
Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization
H Kawamura, X Li, K Goishi, LA van Meeteren, L Jakobsson, ...
Blood, The Journal of the American Society of Hematology 112 (9), 3638-3649, 2008
Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid
R Dusaulcy, C Rancoule, S Grès, E Wanecq, A Colom, C Guigné, ...
Journal of lipid research 52 (6), 1247-1255, 2011
Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis
Z Pamuklar, L Federico, S Liu, M Umezu-Goto, A Dong, M Panchatcharam, ...
Journal of Biological Chemistry 284 (11), 7385-7394, 2009
Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine
LA van Meeteren, F Frederiks, BNG Giepmans, MFF Pedrosa, ...
Journal of Biological Chemistry 279 (12), 10833-10836, 2004
Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity
CG Ferguson, CS Bigman, RD Richardson, LA van Meeteren, ...
Organic letters 8 (10), 2023-2026, 2006
Synthesis, structure− activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARγ, and …
GG Durgam, T Virag, MD Walker, R Tsukahara, S Yasuda, K Liliom, ...
Journal of medicinal chemistry 48 (15), 4919-4930, 2005
Autotaxin (NPP-2) in the brain: cell type-specific expression and regulation during development and after neurotrauma
NE Savaskan, L Rocha, MR Kotter, A Baer, G Lubec, LA Van Meeteren, ...
Cellular and Molecular Life Sciences 64, 230-243, 2007
Discovery and optimization of boronic acid based inhibitors of autotaxin
HMHG Albers, LA van Meeteren, DA Egan, EW van Tilburg, ...
Journal of medicinal chemistry 53 (13), 4958-4967, 2010
Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting
LA van Meeteren, M Thorikay, S Bergqvist, E Pardali, CG Stampino, ...
Journal of Biological Chemistry 287 (22), 18551-18561, 2012
NRP1 presented in trans to the endothelium arrests VEGFR2 endocytosis, preventing angiogenic signaling and tumor initiation
S Koch, LA van Meeteren, E Morin, C Testini, S Weström, H Björkelund, ...
Developmental cell 28 (6), 633-646, 2014
TGF-β receptor signaling pathways in angiogenesis; emerging targets for anti-angiogenesis therapy
L A van Meeteren, MJ Goumans, P ten Dijke
Current pharmaceutical biotechnology 12 (12), 2108-2120, 2011
ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis
Z Liu, F Lebrin, JA Maring, S van den Driesche, S van der Brink, ...
PloS one 9 (1), e86273, 2014
The system can't perform the operation now. Try again later.
Articles 1–20